Coronaviral Infection (COVID-19) in Children (Situation on June 2020)
https://doi.org/10.15690/pf.v17i3.2121
Abstract
Dear friends, colleagues! The number of cases of new coronaviral infection has begun to decrease over the past two months, whereas, the number of publications on the accumulated experience of diagnosis, management and rehabilitation is increasing. It allows us to share knowledge and enhance our tactics. We present updated data on SARS-CoV-19 coronavirus and the disease it causes in this review.
Keywords
coronaviral infection,
COVID-19,
SARS-CoV-2,
diagnostics,
clinical signs,
prevention,
treatment,
children
Supporting agencies: Not specified.
About the Authors
Leyla S. Namazova-Baranova
Research Institute of Pediatrics and Children's Health in «Central Clinical Hospital of the Russian Academy of Sciences»;
Pirogov Russian National Research Medical University;
Belgorod State National Research University
Russian Federation
Moscow
Disclosure of interest: The authors of the article confirmed the absence of a conflict of interest, which must be reported.
Russian Federation
Moscow
Disclosure of interest: The authors of the article confirmed the absence of a conflict of interest, which must be reported.
Alexander A. Baranov
Research Institute of Pediatrics and Children's Health in «Central Clinical Hospital of the Russian Academy of Sciences»
Russian Federation
Moscow
Disclosure of interest: The authors of the article confirmed the absence of a conflict of interest, which must be reported.
Russian Federation
Moscow
Disclosure of interest: The authors of the article confirmed the absence of a conflict of interest, which must be reported.
References
1. Ogimi C, Kim YJ, Martin ET, et al. What’s New With the Old Coronaviruses? J Pediatric Infect Dis Soc. 2020;9(2):210–217. doi: 10.1093/jpids/piaa037.
2. Jiang S, Shi Z, Shu Y, et al. A distinct name is needed for the new coronavirus. Lancet. 2020;395(10228):949. doi: 10.1016/S0140-6736(20)30419-0.
3. Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage В betacoronaviruses. Nat Microbiol. 2020;5(4):562–569. doi: 10.1038/s41564-020-0688-y.
4. Zhou P, Yang X, Wang X, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi: org/10.1038/s41586-020-2012-7.
5. Khera R, Clark C, Lu Y, et al. Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19. medRxiv. 2020;2020.05.17.20104943. doi: 10.1101/2020.05.17.20104943.
6. Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146(1):203–206.e3. doi: 10.1016/j.jaci.2020.04.009.
7. Kimura H, Francisco D, Conway M, et al. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J Allergy Clin Immunol. 2020;146(1):80–88.e8. doi: 10.1016/j.jaci.2020.05.004.
8. Zang R, Gomez Castro MF, Mccune BT, et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020;5(47): eabc3582. doi: 10.1126/sciimmunol.abc3582.
9. Gemmati D, Bramanti B, Serino ML, et al. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? Int J Mol Sci. 2020;21(10):3474. doi: 10.3390/ijms21103474.
10. Dong Y, Мо Х, Нu Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020; 145(6): e20200702. doi: 10.1542/peds.2020-0702.
11. Du Z, Xu X, Wu Y, et al. Serial Interval of COVID-19 among Publicly Reported Confirmed Cases. Emerg Infect Dis. 2020;26(6):1341–1343. doi: 10.3201/eid2606.200357.
12. Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi: 10.1001/jamaophthalmol.2020.1291.
13. Recommendations for Investigational COVID-19 Convalescent Plasma [updated May 1, 2020; cited June 29, 2020]. Available online: https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma.
14. Shen K, Yang Y. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue. World J Pediatr. 2020;16(3):219–221. doi: 10.1007/s12519-020-00344-6.
15. Molloy EJ, Bearer CF. COVID-19 in children and altered inflammatory responses. Pediatr Res. 2020 Apr 3. Online ahead of print. doi: 10.1038/s41390-020-0881-y.
16. Cristiani L, Mancino E, Matera L, et al. Will children reveal their secret? The coronavirus dilemma. Eur Respir J. 2020;55(4):2000749. doi: 10.1183/13993003.00749-2020.
17. Xu Y, Li X, Zhu B, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26(4):502–505. doi: 10.1038/s41591-020-0817-4.
18. Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus–infected pneumonia. J Med Virol. 2020;92(6):680–682. doi: org/10.1002/jmv.25742.
19. Zheng M, Gao Y, Wang G, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17(5):533–535. doi: 10.1038/s41423-020-0402-2.
20. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi: 10.1016/S0140-6736(20)30628-0.
21. PICS Statement: Increased number of reported cases of novel presentation of multisystem inflammatory disease [updated April 27, 2020; cited June 29, 2020]. Available online: https://picsociety.uk/wp-content/uploads/2020/04/PICS-statement-re-novel-KD-C19-presentation-V-2-27042020.pdf.
22. Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607–1608. doi: 10.1016/S0140-6736(20)31094-1.
23. Guidance: Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 [updated May, 2020; cited June 29, 2020]. Available online: https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.pdf.
24. 2020 Health Alert #13: Pediatric Multi-System Inflammatory Syndrome Potentially Associated with COVID-19 [updated May 4, 2020; cited June 29, 2020]. Available online: https://www1.nyc.gov/assets/doh/downloads/pdf/han/alert/2020/covid-19-pediatric-multi-system-inflammatory-syndrome.pdf.
25. Jenco M. CDC details COVID-19-related inflammatory syndrome in children [updated May 14, 2020; cited June 29, 2020]. Available online: https://www.aappublications.org/news/2020/05/14/covid19inflammatory051420.
26. Jenco M. Experts shed more light on COVID-19-related inflammatory syndrome in children [updated May 20, 2020; cited June 29, 2020]. Available online: https://www.aappublications.org/news/2020/05/20/covid19inflammatorysyndrome052020.
27. Greene AG, Saleh M, Roseman E, Sinert R. Toxic shock-like syndrome and COVID-19: A case report of multisystem inflammatory syndrome in children (MIS-C). Am J Emerg Med. 2020 Jun 6;S0735-6757(20)30492-7. Online ahead of print. doi: 10.1016/j.ajem.2020.05.117.
28. Schnapp A, Abulhija H, Maly A, et al. Introductory histopathological findings may shed light on COVID-19 paediatric hyperinflammatory shock syndrome. J Eur Acad Dermatol Venereol. 2020 Jun 13;10.1111/jdv.16749. Online ahead of print. doi: 0.1111/jdv.16749.
29. Waltuch T, Gill P, Zinns LE, et al. Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department. Am J Emerg Med. 2020 May 23;S0735-6757(20)30403-4. Online ahead of print. doi: 10.1016/j.ajem.2020.05.058.
30. Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094. doi: 10.1136/bmj.m2094.
31. Grimaud M, Starck J, Levy M, et al. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care. 2020;10:69. doi: 10.1186/s13613-020-00690-8.
32. Mazza S, Sorce A, Peyvandi F, et al. A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis. Gut. 2020;69(6):1148–1149. doi: 10.1136/gutjnl-2020-321183.
33. Ng SC, Tilg H. COVID-19 and the gastrointestinal tract: more than meets the eye. Gut. 2020;69(6):973–974. doi: 10.1136/gutjnl-2020-321195.
34. Krzysztof NJ, Christoffer LJ, Rahul K, et al. (2020). Age, inflammation and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease. Gastroenterology. 2020 May 12;S0016-5085(20)30653-3. Online ahead of print. doi: 10.1053/j.gastro.2020.05.030.
35. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246–251. doi: 10.1016/j.jhin.2020.01.022.
36. Van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARSCoV-1. N Engl J Med. 2020;82(16):1564–1567. doi: 10.1056/NEJMc2004973.
37. Nishiura H, Linton NM, Akhmetzhanov AR. Serial interval of novel coronavirus (COVID-19) infections. Int J Infect Dis. 2020;93:284–286. doi: 10.1016/j.ijid.2020.02.060.
38. Du Z, Xu X, Wu Y, et al. Serial Interval of COVID-19 among Publicly Reported Confirmed Cases. Emerg Infect Dis. 2020;26(6):1341–1343. doi: 10.3201/eid2606.200357.
39. Kam K-Q, Yung CF, Cui L, et at. A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load. Clin Infect Dis. 2020 Feb 28;ciaa201. Online ahead of print. doi: 10.1093/cid/ciaa201.
40. Cai J, Xu J, Lin D, et al. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020 Feb 28;ciaa198. Online ahead of print. doi: 10.1093/cid/ciaa198.
41. Qiu H. Wu J, Hong L, et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20(6):689–696. doi: 10.1016/S1473-3099(20)30198-5.
42. Xu Y, Li X, Zhu B, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26(4):502–505. doi: 10.1038/s41591-020-0817-4.
43. Young BE, Ong SW, Kalimuddin S, et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488–1494. doi: 10.1001/jama.2020.3204.
44. Cao Q, Chen YC, Chen CL, Chiu CH. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. J Formos Med Assoc. 2020;119(3):670–673. doi: 10.1016/j.jfma.2020.02.009.
45. Su L, Ma X, Yu H, et al. The different clinical characteristics of corona virus disease cases between children and their families in China — the character of children with COVIO-19. Emerg Microbes Infect. 2020;9(1):707–713. doi: 10.1080/22221751.2020.1744483.
46. Мa Х, Su L, Zhang Y, et al. Do children need a longer time to shed SARS-CoV-2 in stool than adults? J Microbiol Immunol Infect. 2020;53(3):373–376. doi: 10.1016/j.jmii.2020.03.010.
47. Stadnytskyi V, Bax CE, Bax A, Anfinrud P. The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission. Proc Natl Acad Sci U S A. 2020;117(22):11875–11877. doi: 10.1073/pnas.2006874117.
48. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177–1179. doi: 10.1056/NEJMc2001737.
49. Zeng H, Хu С, Fan J, et al. Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA. 2020;323(18):1848–1849. doi: 10.1001/jama.2020.4861.
50. Dong L, Tian J, He S, et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA. 2020;323(18):1846–1848. doi: 10.1001/jama.2020.4621.
51. Goldstein E, Lipsitch M. Temporal rise in the proportion of younger adults and older adolescents among coronavirus disease (COVID-19) cases following the introduction of physical distancing measures, Germany, March to April 2020. Euro Surveill. 2020;25(17):2000596. doi: 10.2807/1560-7917.ES.2020.25.17.2000596.
52. Coronavirus disease (COVID-2019) situation reports. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
53. Тagarro A, Epalza С, Santos М, et al. Screening and severity of Coronavirus Disease 2019 (COVID-19) in children in Madrid, Spain. JAMA Pediatr. 2020 Apr 8;e201346. Online ahead of print. doi: 10.1001/jamapediatrics.2020.1346.
54. Wei M, Yuan J, Liu Y, et al. Novel Coronavirus infection in hospitalized infants under 1 year of age in China. JAMA. 2020;323(13):1313–1314. doi: 10.1001/jama.2020.2131.
55. Lu X, Zhang L, Du H, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020;382(17):1663–1665. doi: 10.1056/NEJMc2005073.
56. Davies NG, Klepac P, Liu Y, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med. 2020 Jun 16. doi: 10.1038/s41591-020-0962-9.
57. Feulconbridge G. Children with COVID-19 may be less contagious than adults, two UK epidemiologists say [updated May 19, 2020; cited June 29, 2020]. Available online: https://ru.reuters.com/article/healthNews/idUKKBN22V1K1.
58. Gudbjartsson DF, Helgason A, Jonsson H, et al. Spread of SARSCoV-2 in the Icelandic Population. N Engl J Med. 2020;382(24):2302–2315. doi: 10.1056/NEJMoa2006100.
59. Worcester S. COVID-19 characteristics differ in children vs adults. 2020. Available online: https://www.medscape.com/viewarticle/926805.
60. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5.
61. Zhu N, Zhang D, Wang W, et al. A novel Coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi: 10.1056/NEJMoa2001017.
62. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032.
63. Baez D. Clinical findings of 6 children with COVID-19, risks factors associated with COVID-19 death, and detection of SARSCoV-2 in different clinical specimens. Mar 13, 2020. Available online: http://www.anmco.it/uploads/u_cms/media/2020/3/b0f67d369884729177067cdc663b497c.pdf.
64. Lu X, Liqiong ZL, Du H, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020;382(17):1663–1665. doi: 10.1056/NEJMc2005073.
65. Chan JF, Yuan S, Kok K, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi: 10.1016/S0140-6736(20)30154-9.
66. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
67. Zhang J, Dong X, Cao Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. doi: 10.1111/all.14238.
68. Boulos MN, Geraghty EM. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics. Int J Health Geogr. 2020;19(1):8. doi: 10.1186/s12942-020-00202-8.
69. Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–1844. doi: 10.1001/jama.2020.3786.
70. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–815. doi: 10.1016/S0140-6736(20)30360-3.
71. The Daily Star. Coronavirus suspicion: 7-month-old baby sent to Dhaka from isolation ward in Kushtia. 2020. Available online: https://www.thedailystar.net/coronavirus-suspicion-in-kushtia-7-month-old-baby-isolation-ward-1886209.
72. Zeng L, Xia S, Yuan W, et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates воrn to mothers with COVID-19 in Wuhan, China. JAMA Pediatrics. 2020;174(7):722–725. doi: 10.1001/jamapediatrics.2020.0878.
73. Xia W, Shao J, Guo Y, et al. Clinical and CT features in pediatric patients with COVID- 19 infection: Different points from adults. Pediatr Pulmonol. 2020;55(5):1169–1174. doi: 10.1002/ppul.24718.
74. Chen ZM, Fu JF, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020;16(3):240–246. doi: 10.1007/s12519-020-00345-5.
75. Liu W, Zhang Q, Chen J, et al. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. N Engl J Med. 2020;382(14):1370–1371. doi: 10.1056/NEJMc2003717.
76. Zheng F, Liao C, Fan QH, et al. Clinical characteristics of children with Coronavirus Disease 2019 in Hubei, China. Curr Med Sci. 2020;40(2):275–280. doi: 10.1007/s11596-020-2172-6.
77. Marzano AV, Genovese G, Fabbrocini G, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280–285. doi: 10.1016/j.jaad.2020.04.044.
78. Genovese G, Colonna C, Marzano AV. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: a diagnostic clue? Pediatr Dermatol. 2020;37(3):435–436. doi: 10.1111/pde.14201.
79. Politi LS, Salsano E, Grimaldi M. Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia. JAMA Neurol. 2020 May 29. Online ahead of print. doi: 10.1001/jamaneurol.2020.2125.
80. Benameur K, Agarwal A, Auld SC, et al. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020. Emerg Infect Dis. 2020;26(9). Online ahead of print. doi: 10.3201/eid2609.202122.
81. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):1–9. doi: 10.1001/jamaneurol.2020.1127.
82. Zubair AS, McAlpine LS, Gardin T, et al. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020 May 29. Online ahead of print. doi: 10.1001/jamaneurol.2020.2065.
83. Gao Y, Li T, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;92(7):791–796. doi: 10.1002/jmv.25770.
84. Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763–1770. doi: 10.1016/S0140-6736(20)31189-2.
85. Li W, Cui H, Li K, et al. Chest computed tomography in children with COVID-19 respiratory infection. Pediatr Radiol. 2020;50(6):796–799. doi: 10.1007/s00247-020-04656-7.
86. Henry BM, Lippi G, Plebani M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med. 2020;58(7):1135–1138. doi: 10.1515/cclm-2020-0272.
87. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7.
88. Guo L, Ren L, Yang S, et at. Profiting early humorat response to diagnose novel Coronavirus Disease (COVID-19). Clin Infect Dis. 2020 Mar 21;ciaa310. doi: 10.1093/cid/ciaa310.
89. Kucirka LM, Lauer SA, Laeyendecker O, et al. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure. Ann Intern Med. 2020 May 13;M20-1495. Online ahead of print. doi: 10.7326/M20-1495.
90. Cui Y, Tian M, Huang D, et al. A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage. J Infect Dis. 2020;221(11):1775–1781. doi: 10.1093/infdis/jiaa113.
91. Turner D, Huang Y, Martin-de-Carpi J, et al. COVID-19 and paediatric inflammatory bowel diseases: global experience and provisional guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN. J Pediatr Gastroenterol Nutr. 2020;70(6):721–723. doi: 10.1097/MPG.0000000000002729.
92. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi: 10.1016/S0140-6736(20)30154-9.
93. DeBiasi RL, Song X, Delaney M, et al. Severe COVID-19 in Children and Young Adults in the Washington, DC Metropolitan Region. J Pediatr. 2020;223:199–203.e1. doi: 10.1016/j.jpeds.2020.05.007.
94. Namazova-Baranova LS, Baranov AA. Coronavirus infection in children (Situation on February 2020). Pediatric pharmacology. 2020;17(1):7–11. (In Russ). doi: 10.15690/pf.v17i1.2076.
95. D’Antiga L. Coronavimses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl. 2020;26(6):832–834. doi: 10.1002/lt.25756.
96. Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146(1):203–206.e3. doi: 10.1016/j.jaci.2020.04.009.
97. Jancin B. TNF Inhibitors May Dampen COVID-19 Severity. May 21, 2020. Available online: https://www.medscape.com/viewarticle/930913.
98. Louapre C, Collongues N, Stankoff B, et al. Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis. JAMA Neurol. 2020 June 26;e202581. Online ahead of print. doi: 10.1001/jamaneurol.2020.2581.
99. Rasmussen SA, Smulian JC, Lednicky JA, et al. Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know. Am J Obstet Gynecol. 2020;222(5):415–426. doi: 10.1016/j.ajog.2020.02.017.
100. Li Y, Zhao R, Zheng S, et al. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China. Emerg Infect Dis. 2020;26(6):1335–1336. doi: 10.3201/eid2606.200287.
101. Lu Q, Shi Y. Coronavirus disease (COVID-19) and neonate: What neonatologist need to know. J Med Virol. 2020;92(6):564–567. doi: 10.1002/jmv.25740.
102. Zhu H, Wang L, Fang C, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51–60. doi: 10.21037/tp.2020.02.06.
103. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [updated June, 2020; cited June 29, 2020]. Available online: https://www.covid19treatmentguidelines.nih.gov.
104. Boulware DR, Pullen MF, Bangdiwala AS, et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 [published online ahead of print, 2020 Jun 3]. N Engl J Med. 2020;NEJMoa2016638. doi:10.1056/NEJMoa2016638
105. FitzGerald GA. Misguided drug advice for COVID-19. Science. 2020;367(6485):1434. doi: 10.1126/science.abb8034.
106. Sheahan TP, Sims AC, Leist SR, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020;11(1):222. doi: 10.1038/s41467-019-13940-6.
107. Martinez MA. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob Agents Chemother. 2020;64(5):e00399-20. doi: 10.1128/AAC.00399-20.
108. Yao X, Ye F, Zhang M, et al. In Vitro Antiviral activity and projection of optimized dosing design of Hydroxychloroquine for the treatment of severe acute respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 Mar 9;ciaa237. doi: 10.1093/cid/ciaa237.
109. Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382(24):2327–2336. doi: 10.1056/NEJMoa2007016.
110. Сaо В, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382(19):1787–1799. doi: 10.1056/NEJMoa2001282.
111. Gautret P, Lagier J, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial. Int J Antimicrob Agents. 2020 Mar 20;105949. Online ahead of print. doi: 10.1016/j.ijantimicag.2020.105949.
112. Chang R, Sun W. Repositioning chloroquine as ideal antiviral prophylactic against COVID-19 — time is now. 2020;2020030279. doi: 10.20944/preprints202003.0279.v1.
113. Advisory on the use of hydroxy-chloroquine as prophylaxis for SARS-CoV-2 infection. Recommendation. 2020. Available online: https://www.mohfw.gov.in/pdf/AdvisoryontheuseofHydroxychloroquinasprophylaxisforSARSCoV-2infection.pdf.
114. Velthuis AJ, van den Worm SH, Sims AC, et al. Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010;6(11):e1001176. doi: 10.1371/journal.ppat.1001176.
115. Santoli JM, Lindley MC, DeSilva MB, et al. Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(19):591–593. doi: 10.15585/mmwr.mm6919e2.
116. Cash, R., & Patel, V. (2020). Has COVID-19 subverted global health? Lancet. 2020;395(10238):1687–1688. doi: .org/10.1016/S0140-6736(20)31089-8.
117. Santoli JM, Lindley MC, DeSilva MB, et al. Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020. MMWR Morb Mortal Wkly Rep 2020;69:591–593. doi: http://dx.doi.org/10.15585/mmwr.mm6919e2
118. Hoffmann M, Kleine-Weber H. Schroeder S, et al. SARS-CoV-2dCell entry depens on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. doi: 10.1016/j.cell.2020.02.052.
119. Yamamoto M, Matsuyama S, Li X, et al. Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome Coronavirus S Protein-Mediated membrane fusion using the splitprotein-based cell-cell fusion assay. Antimicrob Agents Chemother. 2016;60(11):6532–6539. doi: 10.1128/AAC.01.
120. Bousquet J, Anto JM, Iaccarino G, et al. Is diet partly responsible for differences in COVID-19 death rates between and within countries? Clin Transl Allergy. 2020;10:16. doi: 10.1186/s13601.
121. Parikh PA, Shah BV, Phatak AG, et al. COVID-19 Pandemic: Knowledge and Perceptions of the Public and Healthcare Professionals. Cureus. 2020;12(5):e8144. doi: 10.7759/cureus.8144.
Review
For citations:
Namazova-Baranova L.S., Baranov A.A. Coronaviral Infection (COVID-19) in Children (Situation on June 2020). Pediatric pharmacology. 2020;17(3):162-178. (In Russ.) https://doi.org/10.15690/pf.v17i3.2121
Views:
1114
Email this article 